Skip to content
OpenCapital
Get started

OraSure Technologies OSUR Sample Management Solutions — Net revenues

Other product segments

HIV
$13.02M+0.9%
HCV
$2.66M-38.5%
Other Product And Services Revenues
$1.62M+109%
Non-product and services revenues
$1.55M+65.8%
COVID-19
$18K-96.1%
Risk Assessment Testing
$0-100%

Similar metrics at other companies

Azenta logo
AZTASample Management Solutions — Total Revenue
$81.09M+1.6%
Azenta logo
AZTASample Repository Services — Total Revenue
$36.79M+15.2%
John Wiley & Sons, Inc. logo
WLYBResearch Solutions — Revenue, net
$36.5M-3.1%
Agilent Technologies logo
ALife Sciences and Diagnostics Markets — Net revenue
$732M+11.9%
Precigen logo
PGENProduct revenues, net — Total revenues
$21.83M+10,653%
Twist Bioscience Corporation logo
TWSTDNA synthesis and protein solutions — Revenue
$53.27M+27.9%

Other financials

Income statement

See full
Revenue$27.9M-6.7%
Gross profit$11.8M-4.0%
Operating income-$23.3M-31.1%
Net income-$22.4M-39.5%
EPS (diluted)-$0.32-52.4%

Balance sheet

See full
Cash & equivalents$177.0M-28.5%
Total debt$12.7M-10.9%
Total equity$313.3M-20.9%
Total assets$379.2M-17.1%

Cash flow

See full
Operating cash flow-$13.9M+29.6%
CapEx$913.0K+117%
Free cash flow-$14.8M+26.5%

Valuation

See full
Market cap$303.62M+35.3%
Enterprise value$139.32M-1,654%
P/S2.7×+1.3×

Profitability

See full
Gross margin42.2%+0.4pp
Operating margin-68.6%-149pp
Net margin-66.4%-115pp
FCF margin-42.4%-43.3pp

Returns & leverage

See full
Return on equity-21.2%-50.4pp
Debt / equity0×0.0×
Current ratio5.5×-6.9×

Where this comes from

Reported directly by OraSure Technologies in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: OraSure Technologies’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about OraSure Technologies's sample management solutions — net revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OraSure Technologies's sample management solutions — net revenues?
OraSure Technologies (OSUR) reported sample management solutions — net revenues of $9.06M in Q1 2026.
How has OraSure Technologies's sample management solutions — net revenues changed year-over-year?
OraSure Technologies's sample management solutions — net revenues decreased by 0.6% year-over-year, from $9.11M to $9.06M.
What is the long-term trend for OraSure Technologies's sample management solutions — net revenues?
Over 4 years (2021 to 2025), OraSure Technologies's sample management solutions — net revenues has grown at a -14.7% compound annual growth rate (CAGR), from $72.6M to $38.36M.
What does sample management solutions — net revenues mean?
This metric represents the total gross revenue generated from the sale of products and services within the molecular solutions segment, specifically focusing on kits for the collection, stabilization, and transport of genetic material. It serves as a key indicator of market demand for the company's specialized sample management technologies used in molecular diagnostics and research applications. Tracking this revenue stream helps investors assess the commercial performance and growth trajectory of the company's molecular solutions business unit.